Sign in
4

Changes in Ownership

Benitec Biopharma Inc. Filed Acc 0001012975-25-000718

Options or other derivatives

  • Director acquired 28,517 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Mates Sharon Director 2025-11-05 Grant or award · Options (right to buy) +28,517 28,517 D: show line 1 in the form
Loading xslF345X05/form4.xml…